TIP-16. Low and Intermediate Grade Glioma Umbrella Study of Molecular Guided TherapieS (LUMOS2) study

Subotheni Thavaneswaran(The University of Sydney), Hui Gan(Austin Hospital), Warren Mason(Princess Margaret Cancer Centre), Chris J. O’Callaghan(Unknown), Benhur Amanuel(Edith Cowan University), Brandon Lau(Sir Charles Gairdner Hospital), Rosemary Harrup(University of Tasmania), Elizabeth H Barnes, Ganessan Kichenadasse(Flinders University), Hao‐Wen Sim(The University of Sydney), David Roberge(Centre Hospitalier de l’Université de Montréal), Rebecca Harrison(University Hospitals of Leicester NHS Trust), Lucas Adda(The University of Sydney), James Lynam, Marshall Pitz(CancerCare Manitoba), James R. Whittle(Walter and Eliza Hall Institute of Medical Research), Roel G.W. Verhaak(University of New Haven), Elizabeth Ahern(Monash Health), Anthony Dowling(Monash University), Benjamin Y. Kong(Prince of Wales Hospital), Michael E. Buckland(The University of Sydney), Helen Wheeler(The University of Sydney), Cynthia Hawkins(Hospital for Sick Children), Mandy L. Ballinger(Garvan Institute of Medical Research), Richard De Abreu Lourenço(University of Technology Sydney), Bryan W. Day(Queensland University of Technology), David M. Thomas(UNSW Sydney), Paula de Robles(Cancer Institute (WIA)), Zarnie Lwin(The University of Queensland), Eng-Siew Koh(Liverpool Hospital), M. Maddula(UNSW Sydney), John Simes(The University of Sydney), Sachie Pallimulla(The University of Sydney), Sonia Yip(The University of Sydney), Andrew Norrie(Queen's University), Adam Cooper(Liverpool Hospital)
Neuro-Oncology
November 1, 2025
Cited by 0


Related Papers